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1. Introduction  
As part of an on-going investigation into bis-imidazolium salts 
atmospherically friendly solvents and particularly ionic 
liquids,1,2,3,4 we herein  disclose our findings on the utility of 
ultra-high pressure (UHP) at 1.9 GPa for the direct synthesis of 
bis(imidazolium-3-yl)alkane dichlorides via consecutive 
Menshutkin reactions as illustrated in Scheme 1. 
 
Scheme 1.  The one-pot consecutive Menshutkin reaction 
UHP conditions enable control over reactions in a manner 
dependent upon the volume changes associated with different 
pathways. In accord with Le Chatelier’s principle, promoted 
reactions are those proceeding to species whose formation is 
accompanied by a decrease in total system volume, be that a 
transition state for kinetically controlled processes or a product 
for thermodynamically controlled processes (Fig. 1).5,6 
The sensitivity of the kinetic response to pressure is quantified 
by the so-called volume of activation7 (∆V‡), as defined in (1), 
where ∆V‡ represents the difference in volume between starting 
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Figure 1.  Depiction of volume contractions that lead to the 
influence of pressure on reactions in liquid media 
Ionogenic reactions are particularly strongly promoted by 
UHP as a result of electostriction8 reducing the volume of the 
solvated species due to the attractive effect that developing 
charges exert on the solvent.9 The Menshutkin synthesis of 
imidazolium salts from imidazole and dichloroalkanes is 
intrinsically ionogenic, proceeding through a polar transition 
state to an ammonium salt product and thus lends itself well to 
acceleration by the application of UHP.10,11,12 
Although, the reactivity of dichloromethane towards 
nucleophilic substitution is generally considered to be low the 
assumption of complete inactivity, in particular towards SN2 
reactions, is unwarranted. It has been previously reported that 
tertiary amines13,14,15 and pyridine16 react appreciably, albeit 
slowly, with dichloromethane at ambient temperature and 
pressure. These reactions have been discovered serendipitously,17 
for example, in basified HPLC solvents.18 
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The ultra-high pressure Menshutkin reaction of N-substituted imidazoles and α,ω-
dichloroalkanes provides access to a wide variety of bis(imidazoliumyl)alkane dichlorides in an 
efficient, one-pot process. Although the substitution reactions of dichloromethane at ambient 
pressure can be exceedingly slow, at 1.9 GPa, syntheses are usually quantitative in under 24 h. 
Reactions involving congested imidazole starting materials, that otherwise terminate after 
formation of the mono-imidazolium salt, are driven to the bis-imidazolium salt at 1.9 GPa. The 
rates of reaction increase with α,ω-dichloroalkane chain length, decrease with increasing bulk 
and imidazole N-substituent length, and the reactions of the more hindered imidazoles are more 
sensitive to the pressure-rate enhancement. 
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The preparation of methylene-bridged imidazolium salts from 
dichloromethane is difficult to achieve with good conversions, 
although it is sometimes possible to carry out reactions under 
forcing conditions, such as using a sealed bomb at elevated 
temperatures. It is more common for dichloromethane to be 
replaced with the appreciably more reactive dibromomethane or 
diiodomethane, thus necessitating a subsequent anion metathesis 
to obtain the chloride salt. Unfortunately, these procedures too 
can fail for more sterically hindered nucleophiles, such as 1-
methyl-2-phenylimidazole. 
Such compounds have received recent attention for their 
utility as high-performance anti-wear additives19 for use under 
extreme conditions. For example, in space and aeronautical 
niches, where elevated temperature and exceedingly low 
pressures are routine, ionic-liquids as viscous, and practically 
non-volatile, substances are well-suited.20 Some of those reported 
by Yao and co-workers, based on bis(1,2-
dimethylimidazoliumyl)decane, were found to exhibit excellent 
tribological characteristics.21 These same bis-imidazolium salts 
belong to the relatively new family of gemini surfactants,22 with 
some examples being at least three-orders of magnitude more 
effective at reducing surface tension, and two-orders more 
efficient at forming micelles, than mono-imidazolium salts.23 To 
investigate the properties of these compounds, we pursued a 
direct and universal synthesis. 
2. Results and Discussion 
A range of symmetrical bis(imidazoliumyl)alkane dichlorides 
was synthesised from the corresponding imidazoles and α,ω-
dichloroalkanes (Scheme 1, Table 1). Whilst at ambient pressure 
dichloromethane was essentially unreactive towards any of the 
imidazoles, at 1.95 GPa some reactions were approaching 
completion within 24 h. Except for the reaction with 
dichloromethane, 1-methylimidazole reacted extremely rapidly 
with homologous ,-dichloroalkanes at 1.95 GPa, with most 
approaching completion within 3 hours. Reactions of more 
congested imidazoles were slower, but generally complete within 
2–3 days at 1.95 GPa. 
Increasing the degree of substitution of and hence steric 
hindrance around the imidazole nucleus resulted in decreased 
reaction rates with all ,-dichloroalkanes, as is to be expected 
of bimolecular reactions. For example, rates decreased in the 
order 1-methylimidazole > 1,2-dimethylimidazole > 1,2,4,5-
tetramethylimidazole > 1-methyl-2-phenyl imidazole, with all 
dichloroalkanes. 
In a consecutive sequence, the first step yields the chloroalkyl 
mono-imidazolium salt, and the second step yields the 
bis(imidazolium) product. Reflecting this sequence prior to 
reaction completion, a time dependent product distribution was 
obtained for all α,ω-dichloroalkanes other than dichloromethane. 
An example of a typical reaction progression is illustrated in 
Figure 2. Relative to the ambient pressure reaction, at 1.95 GPa, 
product distributions were shifted towards the bis-adduct. For 
reactions of dichloromethane however, the bis(imidazolium-3-
yl)methane dichloride was the sole product observed. 
In general, the maximum percentages of the intermediate 
mono-imidazolium salt were low and especially so for reactions 
of the longer dichloroalkanes. The largest percentages were 
obtained for reactions of 1,2-dichloroethane, and decreased with 
increasing chain length – the maximum for this transient species 
decreased and occurred later in the reaction progress as the 
dichloroalkane chain length was extended (Fig. 3). In contrast, at 
ambient pressure, the reaction of 1-methyl-2-phenylimidazole 
with ,-dichloroalkanes produced significant quantities of the 
mono-imidazolium salt and, without application of UHP, the 
reaction effectively ended after the first substitution step. 
 
Figure 2. Progression of reaction of 1,2-dimethylimidazole 
and 1,3-dichloropropane at 1.95 GPa and 45 °C, where A, B, 
C and D are the concentrations of the imidazole, 
dichloropropane, the mono-imidazolium salt and the 
bis(imidazolium) salt, respectively. 
 
 
Figure 3. Variation in the early concentrations of mono-
imidazolium salt for reactions of 1,2-dimethylimidazole with 
dichlorobutane (dotted line), dichloropropane (dashed line) 
and dichloroethane (solid line) 
The rate constants observed for the reaction of 1,2-
dimethylimidazole with several dichloroalkanes were estimated 
using the numerical solution to the differential equations and are 
listed in Table 2. 
Table 2. Rate constants for the reactions of 1,2-
dimethylimidazole 
1,2-dimethylimidazole k1 / mol
−1 dm3 s−1 k2 / k1 
1,2-dichloroethane 4.5 ± 0.6×10−5 5.9 ± 0.9 
1,3-dichloropropane 8.8 ± 1.6×10−5 7.1 ± 0.4 
1,4-dichlorobutane 4.2 ± 0.4×10−4 7.6 ± 0.7 
The enhanced proclivity of the reactions to favour the 
bis(imidazolium) product at UHP was apparent for every reaction 
in this study, but was particularly obvious for the reactions of 1-
methyl-2-phenylimidazole which, as stated above, yielded no 
bis(imidazolium) salt at ambient pressure. This effect has also 
been reported for the UHP-promoted consecutive Menshutkin 
reactions of cyclic amines, including pyrrolidines, piperidines 
and morpholines with dichloromethane,24 and pyridine with α,ω-
dichloroalkanes.25 For species involved in the Menshutkin 
reaction, electrostriction increases as the solutes become charged 
and this will be enhanced upon going from the mono-
imidazolium adduct to the bis-imidazolium adduct. Indeed, for 
reactions of tertiary amines with dihaloalkanes,25 this has been 
correlated with the even greater degree of electrostriction 
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Table 1. Results for reactions of N-substituted imidazoles with various dichloroalkanes in chloroform, using conditions, 
A: 1.95 GPa, 60 °C; or B: 1 atm, reflux 
   Isolated product yields 
Imidazole α,ω-dichloroalkane Conditions of bis-imidazolium salt of mono-imidazolium salt 
1-methylimidazole dichloromethane A 
B 
100 % (24 h) 
0 % (120 h) 
0 % (120 h) 
0 % (120 h) 
 1,2-dichloroethane A 
B 
95 % (24 h), 70 % (3 h) 
77 % (24 h) 
2 % 
11 % (24 h) 
 1,3-dichloropropane A 
B 
93 % (3 h), >99 % (24 h) 
83 % (24 h) 
1 % (3 h), 0 % (24 h) 
7 % 
 1,4-dichlorobutane A 
B 
>99 % (3 h) 
85 % (24 h) 
0 % (3 h) 
2 % (24 h) 
 1,5-dichloropentane A 
B 
>99 % (3 h) 
96 % (24 h) 
0 % (3 h) 
5 % (24 h) 
1-ethylimidazole dichloromethane A 
B 
76 % (24 h) 
0 % (120 h) 
0 % (24 h) 
0 % (120 h) 
 1,2-dichloroethane A 
B 
87 % (24 h) 
33 % (24 h) 
8 % (24 h) 
17 % (24 h) 
 1,3-dichloropropane A 
B 
95 % (24 h) 
47 % (24 h) 
2 % (24 h) 
11 % (24 h) 
 1,4-dichlorobutane A 
B 
>99 % (24 h) 
54% (24 h) 
0 % (24 h) 
7 % (24 h) 
1-butylimidazole dichloromethane A 
B 
62 % (24 h) 
0 % (120 h) 
0 % (24 h) 
0 % (120 h) 
 1,2-dichloroethane A 
B 
27 % (3 h), 67 % (24 h) 
20 % (24 h) 
4 % (24 h) 
7 % (24 h) 
 1,3-dichloropropane A 
B 
51 % (3 h), 82 % (24 h) 
31 % (24 h) 
11 % (3 h), 1 % (24 h) 
10 % (24 h) 
 1,4-dichlorobutane A 
B 
70 % (3 h), 95 % (24 h) 
38 % (24 h) 
9 % (3 h), 2 % (24 h) 
8 % (24 h) 
1,2-dimethylimidazole dichloromethane A 
B 
80 % (24 h) 
0 % (120 h) 
0 % (24 h) 
0 % (120 h) 
 1,2-dichloroethane A 
B 
33 % (3 h), 84 % (24 h) 
20 % (24 h) 
15 % (3 h), 2 % (24 h) 
8 % (24 h) 
 1,3-dichloropropane A 
B 
53 % (3 h), >99 % (24 h) 
29 % (24 h) 
14 % (3 h), 0 % (24 h) 
11 % 
 1,4-dichlorobutane A 
B 
60 % (3 h), >99 % (24 h) 
47 % (24 h) 






73 % (24 h) 
0 % (120 h) 
0 % (24 h) 
0 % (120 h) 
 1,2-dichloroethane A 
B 
60 % (3 h), 80 % (24 h) 
18 % (24 h) 
17 % (3 h), 10 % (24 h) 
17 % 
 1,3-dichloropropane A 
B 
93 % (24 h) 
55 % (24 h) 
0 % (24 h) 
18 % 
 1,4-dichlorobutane A 
B 
>99 % (3 h) 
66 % (24 h) 
0 % (3 h) 





27 % (24 h) 
0 % (120 h) 
0 % (24 h) 





 1,2-dichloroethane A 
B 
33 % (24 h) 
0 % (24 h) 
30 % (24 h) 
0 % (24 h) 
 1,3-dichloropropane A 
B 
60 % (24 h) 
0 % (24 h) 
22 % (24 h) 
0 % (24 h) 
 1,4-dichlorobutane A 
B 
71 % (24 h) 
0 % (120 h) 
16 % (24 h) 
14 % (120 h) 
-associated with the second transition state. 
Hence, 2V
  for the second substitution is more negative than 
1V
 for the first substitution and the effect of pressure is to 
increase k2 more than k1, promoting the second step rate to a 
larger degree than the first and causing a diminution of the 
amount of mono-imidazolium intermediate observed. 
For reactions of 1,2-dichloroethane, 1,3-propane and 1,4-
butane this holds true but, by this reasoning, the activation barrier 
should be greatest for dichloromethane; the results however do 
not reflect this. The second alkylation step for the reaction of 
dichloromethane differs to those of the homologous ,-
dichloroalkanes in that the cationic imidazolium group is geminal 
to the leaving group. The cationic nature of the 1-
chloromethylimidazolium intermediate will therefore increase the 
electrophilic character of the methylene carbon. This effect, in 
addition to that derived from the pressure-rate enhancement, 
appears to accelerate the second step to a point where the 
indeterminate monoalkylation product is not detectable. A similar 
situation reported for the reaction of pyridine with 
dichloromethane, wherein no intermediate mono-adduct was 
detected,25 was also ascribed to a significantly larger second rate 
constant.  
Whilst at UHP, all reactions proceeded at roughly comparable 
rates, at ambient pressure reactions of more hindered imidazoles 
were very slow. Thus, a greater increase in reaction rate on 
application of UHP is associated with increasingly hindered 
nucleophiles. This sensitivity to pressure can be rationalised with 
application of the Hammond postulate.26 On affording the 
transition state, excessive crowding of the reaction centre may 
cause an increased elongation of the electrophile-nucleofuge 
bond in the transition state.27 This will tend to increase the 
polarity and charge-separation, to which the activation volume is 
related.28 Subsequently, an increased steric hindrance causes the 
transition state to occur later along the reaction coordinate,29 
more closely resembling the cationic product and being in receipt 
of increased stabilisation due to electrostriction.10,11 Conversely, 
an early transition state is consistent with contemporary analysis 
of the Menshutkin reaction30 providing leeway for the transition 
state position to be delayed.31 
The reactions with dichloromethane of five imidazoles were 
characterised more thoroughly. Over 24 h reactions were 
monitored periodically and the concentration versus time profiles 
fitted using the integrated rate expression are provided in Table 3. 
Table 3. Bimolecular rate constants, k1, for reactions of N-
substituted imidazoles with dichloromethane, at 45 °C and 
1.94 GPa 
N-imidazole k1 / mol
−1 dm3 s−1 
1-methylimidazole 2.1×10−5 ± 3.5×10−6 
1-butylimidazole 1.1×10−5 ± 2.0×10−6 
1,2-dimethylimidazole 1.7×10−5 ± 9.0×10−6 
1,2,4,5-tetramethylimidazole 1.4×10−5 ± 1.7×10−6 
1-methyl-2-phenylimidazole 2.2×10−6 ± 4.0×10−7 
3. Conclusion 
In summary, the ultrahigh pressure Menshutkin reaction 
provides a convenient means of synthesising bis(imidazolium) 
dichloride salts, in generally high yield in under 24 h. The 
method is particularly amenable to support the reactions of 
hindered imidazoles that do not proceed at acceptable rates at 
ambient pressure. 
4. Experimental section 
Ultra-high pressure reactions were performed with a Psika 
Pressure Systems Ltd. (UK) high-pressure hydraulic press using 
5% methanol in castor oil as transmission fluid and 5mL PTFE 
reaction vessels. 
1H-NMR spectra were recorded on a Bruker AMX 400 NMR 
(400 MHz) spectrometer and a Bruker Avance DPX 250 (250 
MHz) spectrometer. Signal positions are recorded as chemical 
shifts () in parts per million (ppm) and referenced to the residual 
solvent peak as an internal standard. 13C-NMR spectra were 
recorded on the same spectrometers at 100 MHz. 
Mass spectra (m/z) were recorded under conditions of 
electrospray ionization (ESI) on a Thermo Scientific LTQ 
Orbitrap mass spectrometer. 
Infrared spectra were obtained on a Perkin Elmer Spectrum 
100 FT–IR Spectrometer with an attenuated total reflection 
(ATR) accessory featuring either a diamond or zinc selenide 
(ZnSe) crystal. The software used was Spectrum Express®. 
4.1. General Procedure 
A mixture of the imidazole (50 mmol) and the dichloroalkane 
(25 mmol) was diluted to 25 mL with chloroform and degassed 
by ultra-sonication. The stock solution was stored in the freezer 
between experimental runs. A 4 mL aliquot of the stock solution 
was introduced into a clean, dry, 5 mL PTFE UHP vessel, sealed 
with a double O-ring stopper and the head-space gas removed by 
inserting a syringe needle. The reaction was then pressurised to 
1.9 GPa at 60 °C. After the requisite reaction time, the apparatus 
was depressurised and the vessel removed. The stopper was 
carefully removed (CAUTION! Potential for pressure build-up) 
and the contents transferred to a round-bottom flask, the UHP 
vessel was washed with acetonitrile and the washings combined 
with the bulk of the reaction mixture. The solvents were removed 
in-vacuo, and the residue dissolved in D2O and analysed 
immediately by 1H-NMR spectroscopy. For yields see Table 1.  
4.2. Bis(1-methylimidazolium-3-yl)methane dichloride 
1H-NMR (250 MHz, D2O): δ 7.69 (2H, bs, C(4/5)-H), 7.51 (2H, 
bs, C(4/5)-H), 6.22 (2H, s, CH2) and 3.88 (3H, s, NCH3); 
13C-
NMR (62.8 MHz D2O): δ 138.1 (CH), 124.9 (CH), 121.7 (CH), 
58.7 (CH2) and 36.2 (CH3). 
m/z (ESI): 177.1133 (M-HCl2˥
+), 
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213.0787 (M-Cl˥+), C9H14N4 requires 177.1135, found 177.1140. 
IR (powder) ν: 3435, 3385, 3079, 3029, 2091, 1739, 1644, 1642, 
1580, 1555, 1474, 1454, 1418, 1330, 1289, 1170, 1079, 1017, 
871, 772, 733, 680, 620, 573 cm-1. Anal. Calcd (%) for 
C9H14N4Cl2.H2O (MW 267.16): C, 40.48; H, 6.04; N, 20.97, 
Found (%): C, 39.74; H, 6.07; N, 20.62. 
4.3. 1,2-Bis(1-methylimidazolium-3-yl)ethane dichloride 
1H-NMR (250 MHz, D2O): δ 8.64 (2H, s, C(2)-H), 7.38 (2H, s, 
C(4/5)-H), 7.31 (2H, s, C(4/5)-H), 4.63 (4H, s, NCH2) and 3.77 
(6H, s, NCH3); 
13C-NMR (62.8 MHz D2O): δ 136.8 (CH), 124.5 
(CH), 122.1 (CH), 48.7 (CH2) and 36.0 (CH3). 
m/z (ESI): 
191.1286 (M-HCl2˥
+), 227.0957 (M-Cl˥+), C10H15N4
2+ requires 
191.1296, found 191.1291. IR (powder) ν: 3381, 3059, 2929, 
2856, 2100, 1738, 1641, 1573, 1561, 1455, 1379, 1342, 1164, 
1114, 850, 773, 715, 638, 619 cm-1. Anal. Calcd (%) for 
C10H16N4Cl2.2H2O (MW 299.20): C, 40.14; H, 6.74; N, 18.72, 
Found (%): C, 39.84; H, 7.50; N, 18.75. 
4.4. 1,3-Bis(1-methylimidazolium-3-yl)propane dichloride 
1H-NMR (250 MHz, D2O): δ 8.67 (2H, s, C(2)-H), 7.39 (2H, bs, 
C(4/5)-H), 7.35 (2H, bs, C(4/5)-H), 4.19 (4H, t, J 7.3 Hz, NCH2), 
3.77 (6H, s, NCH3) and 2.39 (2H, quin, J 7.2 Hz, CH2); 
13C-NMR 
(62.8 MHz, D2O): δ 136.7 (CH), 123.8 (CH), 122.0 (CH), 49.1 
(CH2), 35.7 (CH3) and 29.6 (CH2). 
m/z (ESI): 205.1448 (M-
HCl2˥
+), 241.1201 (M-Cl˥+), C10H15N4
 205.1453, found 205.1448. 
IR (powder) ν: 3369, 3072, 3144, 2124, 1724, 1657, 1562, 1457, 
1328, 1279, 1166, 1092, 1065, 1021, 857, 832, 763, 709, 636, 
618 cm-1. Anal. Calcd (%) for C11H18N4Cl2.1.5H2O (MW 304.22): 
C, 43.43; H, 6.96; N, 18.42 Found (%): C, 43.98; H, 7.54; N, 
18.62. 
4.5. 1,4-Bis(1-methylimidazolium-3-yl)butane dichloride 
1H-NMR (250 MHz, D2O): δ 8.60 (2H, s, C(2)-H), 7.33 (2H, s, 
C(4/5)-H), 7.31 (2H, s, C(4/5)-H), 4.11 (4H, t, J 5.2 Hz, NCH2), 
3.75 (6H, s, NCH3), and 1.76 (4H, quin, J 5.2 Hz, CH2);
 13C-
NMR (62.8 MHz D2O): δ 136.31 (CH), 122.6 (CH), 121.9 (CH), 
48.6 (CH2), 35.6 (CH3) and 26.1 (CH2). 
m/z (ESI): 219.1603 (M-
HCl2˥
+), 255.1358 (M-Cl˥+), C12H20N4 requires 219.1609, found 
219.1604. IR (powder) ν: 3376, 3247, 3145, 3061, 2868, 2958, 
2107, 1643, 1577, 1562, 1454, 1429, 1388, 1364, 1334, 1291, 
1238, 1169, 1156, 937, 859, 799, 695, 651, 625, 607 cm-1). Anal. 
Calcd (%) for C12H20N4Cl2.2H2O (MW 327.25): C, 44.04; H, 
7.39; N, 17.12 Found (%); C, 43.67; H, 7.46; N, 16.73. 
4.6. 1,5-Bis(1-methylimidazolium-3-yl)pentane dichloride 
1H-NMR (250 MHz, D2O): δ 8.58 (2H, s, C(2)-H), 7.33 (2H, bs, 
C(4/5)-H), 7.30 (2H, bs, C(4/5)-H), 4.05 (4H, t, J 7.1 Hz, NCH2), 
3.75 (6H, s, J 2.7 Hz, NCH3), 1.78 (4H, tt, J 8.0 Hz, CH2), and 
1.18 (2H, tt, J 6.2 Hz, CH2); 
13C-NMR (62.8 D2O): δ 135.8 (CH), 
123.5 (CH), 122.1 (CH), 49.7 (CH2), 35.6 (CH3), 28.6 (CH2) and 
22.7 (CH2). 
m/z (ESI): 233.1753 (M-HCl2˥
+), 269.1483 (M-Cl˥+) 
C11H17N4 requires 233.1759, found 233.1753. IR (powder) ν: 
3365, 3261, 3146, 3083, 2975, 2862, 2171, 1790, 1654, 1576, 
1566, 1450, 1425, 1373, 1341, 1272, 1221, 1182, 1082, 984, 898, 
841, 793, 745, 651, 623 cm-1. Anal. Calcd (%) for 
C13H22N4Cl2.2H2O (MW 341.28): C, 45.75; H, 7.68; N, 16.42; 
Found (%): C, 45.16; H, 8.17; N, 16.32. 
4.7. Bis(1,2-dimethylimidazolium-3-yl)methane dichloride 
1H-NMR (250 MHz, D2O): δ 7.48 (2H, bs, C(4/5)-H), 7.39 (2H, 
bs, C(4/5)-H), 6.47 (2H, s, NCH2), 3.73 (6H, s, NCH3), 2.66 (6H, 
s, CCH3); 
13C-NMR (62.8 MHz, D2O): δ 146.2 (C), 123.8 (CH), 
120.5 (CH), 57.2 (CH2), 35.2 (CH3) and 9.4 (CH3); 
m/z (ESI): 
103.0761 (M-Cl2˥
2+), C11H18N4 requires 103.0760, found 
103.0761. IR (powder) ν 3390, 3041, 3016, 2960, 1814, 1713, 
1592, 1529, 1504, 1443, 1413, 1338, 1299, 1259, 1199, 1139, 
1055, 1024, 994, 909, 809, 795, 761, 720, 647, 620, 607 cm-1. 
Anal. Calcd (%) for C11H18N4Cl2.0,5H2O: (MW 286.20): C, 
46.13; H, 6.69; N, 16.50; Found (%): C, 46.02; H, 6.58; N, 19.50. 
4.8. 1,2-Bis(1,2-dimethylimidazolium-3-yl)ethane dichloride 
1H-NMR (250 MHz, D2O): δ 7.32 (2H, bs, C(4/5)-H), 7.16 (2H, 
bs, C(4/5)-H), 4.55 (4H, s, NCH2), 3.71 (6H, s, NCH3), 2.43 (6H, 
s, CCH3). 
13C-NMR (62.8 MHz, D2O): δ 145.1 (C), 123.2 (CH), 
120.8 (CH), 46.9 (CH2), 34.9 (CH3) and 8.6 (CH3); 
m/z (ESI): 
110.0840 (M-Cl2˥
2+) C12H20N4 requires 110.0838, found 
110.0840. IR (powder) ν: 3359, 3121, 3044, 2961, 1587, 1536, 
1422, 1337, 1282, 1243, 1155, 1125, 1053, 784, 749, 728, 666, 
593 cm-1. Anal. Calcd (%) for C12H20N4Cl2.3H2O: (MW 345.27): 
C, 41.74; H, 7.58; N, 16.23; Found (%): C, 41.63; H, 7.02; N, 
16.00. 
4.9. 1,3-Bis(1,2-dimethylimidazolium-3-yl)propane dichloride 
1H-NMR (250 MHz, D2O): δ 7.30 (2H, bs, C(4/5)-H), 7.28 (2H, 
bs, C(4/5)-H), 4.15 (4H, t, J 7.5 Hz, NCH2), 3.69 (6H, s, NCH3), 
2.51 (6H, s, CCH3) and 2.30 (2H, quin, J 7.5 Hz, CH2). 
13C-NMR 
(62.8 MHz, D2O): δ 144.6 (C), 122.6 (CH), 120.4 (CH), 44.8 
(CH2), 34.6 (CH3), 28.9 (CH2) and 8.8 (CH3). 
m/z (ESI): 117.0918 
(M-HCl2˥
2+), C13H22N4 requires 117.0971, found 117.0918. IR 
(powder) ν: 3349, 3263, 3074, 2970, 2131, 1636, 1587, 1535, 
1440, 1377, 1330, 1240, 1191, 1160, 1127, 1048, 879, 808, 766, 
752, 727, 670, 658 cm-1. Anal. Calcd (%) for C13H22N4Cl2.2H2O: 
(MW 341.28): C, 45.75; H, 7.68; N, 16.42; Found (%): C, 45.26; 
H, 7.66; N, 16.13. 
4.10. 1,4-Bis(1,2-dimethylimidazolium-3-yl)butane dichloride 
1H-NMR (250 MHz, D2O): δ 7.23 (4H, bs, C(4/5)-H),  4.05 (4H, 
s, NCH2), 3.56 (6H, s, NCH3), 2.47 (6H, s, CCH3) and 1.08 (4H, 
t, J 7.2 Hz, CH2). 
13C-NMR (62.8 MHz, D2O): δ 145.0 (C), 122.3 
(CH), 120.5 (CH), 47.4 (CH2), 34.5 (CH3), 25.9 (CH2) and 8.7 
(CH3). 
m/z (ESI): 124.0997 (M-Cl2˥
2+), C14H24N4 requires 
124.0995, found 124.0997. IR (powder) ν: 3443, 3381, 3050, 
1587, 1536, 1470, 1365, 1341, 1270, 1242, 1152, 1118, 1037, 
795, 778, 730, 660, 628 cm-1. Anal. Calcd (%) for 
C14H24N4Cl2.1,5H2O: (MW 346.30): C, 48.56; H, 7.86; N, 16.18; 
Found (%): C, 48.52; H, 8.33; N, 15.65. 
4.11. 1,5-Bis(1,2-dimethylimidazolium-3-yl)pentane dichloride 
1H-NMR (250 MHz, D2O): δ 7.25 (4H, bs, C(4/5)-H), 4.02 (4H, 
t, J 7.2 Hz, NCH2), 3.67 (6H, s, NCH3), 2.48 (6H, s, CCH3), 1.74 
(4H, quin, J 7.6 Hz, CH2) and 1.27 (2H, m, CH2). 
13C-NMR (62.8 
MHz, D2O): δ 144.2 (C), 122.1 (CH), 120.6 (CH), 47.8 (CH2), 
34.6 (CH3), 28.2 (CH2), 22.4 (CH2) and 8.8 (CH3); 
m/z (ESI): 
131.1073 (M-Cl2˥
2+), C15H26N4 requires 131.1073, found 
131.1076. IR (powder) ν: 3387, 3036, 2945, 1586 1538, 1514, 
1462, 1420, 1391, 1358, 1338, 1274, 1246, 1190, 1122, 1077, 
1049, 787, 753, 739, 661 cm-1. Anal. Calcd (%) for 
C15H26N4Cl2.4H2O: (MW 405.36): C, 44.44; H, 8.45; N, 13.82; 
Found (%): C, 43.70; H, 7.12; N, 13.07. 
4.12. Bis(1-ethylimidazolium -3-yl)methane dichloride 
1H-NMR (400 MHz, D2O): δ 9.16 (2H, s, C(2)-H), 7.66 (2H, bs, 
C(4/5)-H), 7.55 (2H, bs, C(4/5)-H), 6.59 (2H, s, NCH2), 4.21 
(4H, q, J 7.2 Hz, NCH2CH3), 1.43 (6H, t, J 7.2 Hz, CCH3). 
13C-
NMR (62.8 MHz, D2O): δ 135.2 (CH), 123.4 (CH), 122.0 (CH), 
58.8 (CH2), 45.6 (CH2) and 14.1 (CH3); 
m/z (ESI): 205.1445 (M-
HCl2˥
+), 103.0754 (M-Cl2˥
2+), C11H17N4 requires 205.1448, found 
205.1445. IR (powder) ν: 3362, 3245, 3040, 2983, 2116, 1642, 





1109, 1080, 1034, 958, 916, 885, 805, 763, 666, 618, 607 cm-1. 
Anal. Calcd (%) for C11H18N4Cl2.1H2O: (MW 295.21): C, 44.75; 
H, 6.82; N, 18.98; Found (%): C, 43.85; H, 6.76; N, 18.70. 
4.13. 1,2-Bis(1-ethylimidazolium-3-yl)ethane dichloride 
1H-NMR (400 MHz, D2O): δ 8.74 (2H, s, C(2)-H), 7.52 (2H, bs, 
C(4/5)-H), 7.36 (2H, bs, C(4/5)-H), 4.67 (4H, s, NCH2), 4.17 
(4H, q, J 7.4 Hz, NCH2CH3), 1.42 (6H, t, J 7.4 Hz, CCH3). 
13C-
NMR (62.8 MHz, D2O): δ 135.6 (CH), 123.2 (CH), 122.2 (CH), 
48.8 (CH2), 45.2 (CH2) and 14.4 (CH3); 
m/z (ESI): 219.1601 (M-
HCl2˥
+), 110.0844 (M-Cl2˥
2+), C12H19N4 requires 219.1604, found 
219.1601. IR (powder) ν: 3378, 3140, 3078, 3031, 2875, 2110, 
1639, 1561, 1449, 1409, 1356, 1336, 1302, 1246, 1166, 1122, 
962, 864, 799, 785, 652, 638, 603 cm-1. Anal. Calcd (%) for 
C12H20N4Cl2.2H2O: (MW 327.25): C, 44.04; H, 7.39; N, 17.12; 
Found (%): C, 44.48; H, 8.04; N, 17.33. 
4.14. 1,3-Bis(1-ethylimidazolium-3-yl)propane dichloride 
1H-NMR (400 MHz, D2O): δ 8.73 (2H, s, C(2)-H), 7.44 (2H, bs, 
C(4/5)-H), 7.41 (2H, bs, C(4/5)-H), 4.17 (4H, t, J 7.4 Hz, 
NCH2CH3), 4.16 (4H, q, J 7.4 Hz, NCH2), 1.85 (2H, quin, J 4.7 
Hz, CH2), 1.44 (6H, t, J 7.4 Hz, CH2CH3). 
13C-NMR (62.8 MHz, 
D2O): δ 134.9 (CH), 122.2 (CH), 122.1 (CH), 48.7 (CH2), 44.9 
(CH2), 26.2 (CH2), 14.4 (CH3); 
m/z (ESI): 233.1759 (M-HCl2˥
+), 
117.0912 (M-Cl2˥
2+), C13H21N4 requires 233.1761, found 
233.1759. IR (powder) ν: 3378, 3134, 3048, 2980, 2946, 2866, 
2161, 1564, 1460, 1357, 1258, 1156, 1095, 1050, 958, 824, 779, 
741, 652, 618 cm-1. Anal. Calcd (%) for C13H22N4Cl2.0.5H2O: 
(MW 323.27): C, 49.69; H, 7.38; N, 17.83; Found (%): C, 49.32; 
H, 8.93; N, 17.64. 
4.15. 1,4-Bis(1-ethylimidazolium-3-yl)butane dichloride 
1H-NMR (400 MHz, D2O): δ 8.72 (2H, s, C(2)-H), 7.43 (2H, bs, 
C(4/5)-H), 7.39 (2H, bs, C(4/5)-H), 4.16 (4H, dd, J 4.8 Hz, 
NCH2CH3), 4.18 (4H, t, J 7.6 Hz, NCH2CH2), 1.82 (4H, q, J 4.8 
Hz CH2CH2), 1.44 (6H, t, J 7.2 Hz, CH3). 
13C-NMR (62.8 MHz, 
D2O): δ 135.2 (CH), 122.5 (CH), 122.2 (CH), 46.4 (CH2), 44.9 
(CH2), 29.6 (CH2) and 14.4 (CH3); 
m/z (ESI): 247.1915 (M-
HCl2˥
+), 124.0989 (M-Cl2˥
2+), C14H23N4 requires 247.1917, found 
247.1915. IR (powder) ν: 3379, 3134, 3075, 2976, 2923, 2828, 
1823, 1630, 1556, 1450, 1376, 1304, 1220, 1156, 1055, 1033, 
1018, 958, 916, 796, 784, 649 cm-1. Anal. Calcd (%) for 
C14H24N4Cl2.H2O: (MW 337.29): C, 49.85; H, 7.77; N, 16.61; 
Found (%): C, 50.42; H, 8.16; N, 16.55. 
4.16. 1,5-Bis(1-ethylimidazolium-3-yl)pentane dichloride 
1H-NMR (400 MHz, D2O): δ 8.70 (2H, s, C(2)-H), 7.43 (2H, bs, 
C(4/5)-H), 7.39 (2H, bs, C(4/5)-H), 4.14 (4H, t, J 7.2 Hz, 
NCH2CH2), 4.11 (4H, q, J 7.5 Hz, NCH2CH3), 1.84 (4H, quin, J 
7.6 Hz, CH2), 1.39 (6H, t, J 7.5 Hz, CH2CH3), 1.22 (2H, quin, J 
7.5 Hz, CH2). 
13C-NMR (62.8 MHz, D2O): δ 134.8 (CH), 122.2 
(CH), 122.0 (CH), 49.1 (CH2), 44.8 (CH2), 28.7 (CH2), 22.2 
(CH2), 14.4 (CH3); 
m/z (ESI): 261.2071 (M-HCl2˥
+), 131.1067 
(M-Cl2˥
2+), C15H25N4 requires 261.2074, found 261.2071. IR 
(powder) ν: 3442, 3383, 3086, 3045, 2977, 2200, 2122, 1790, 
1681, 1621, 1577, 1562, 1451, 1385, 1344, 1320, 1268, 1231, 
1193, 1164, 1033, 876, 789, 692, 650, 627, 584 cm-1. 
4.17. Bis(1-butylimidazolium-3-yl)methane dichloride 
1H-NMR (400 MHz, D2O): δ 7.71 (2H, bs, C(4/5)-H), 7.59 (2H, 
bs, C(4/5)-H), 6.63 (2H, s, NCH2), 4.20 (4H, quin, J 7.6 Hz, 
NCH2CH2), 1.78 (6H, quin, J 7.6 Hz, CH2CH2), 1.23 (6H, quin, J 
7.6 Hz, CH2CH2) and 0.82 (6H, t, J 7.6 Hz, CH2CH3). 
13C-NMR 
(62.8 MHz, D2O): δ 136.4 (CH), 123.8 (CH), 122.0 (CH), 58.8 





requires 261.2074, found 261.2072. IR (powder) ν: 3406, 3051, 
2960, 2873, 1794, 1681, 1580, 1560, 1462, 1380, 1320, 1166, 
1114, 906, 802, 768, 717, 665, 612 cm-1. 
4.18. 1,2-Bis(1-butylimidazolium-3-yl)ethane dichloride 
1H-NMR (400 MHz, D2O): δ 8.79 (2H, s, C(2)-H), 7.56 (2H, bs, 
C(4/5)-H), 7.46 (2H, bs, C(4/5)-H), 4.74 (4H, t, J 7.2 Hz, NCH2), 
4.16 (4H, t, J 7.5 Hz, NCH2), 1.78 (4H, quin, J 7.5 Hz, CH2CH2), 
1.19 (4H, q, J 7.2 Hz, CH2CH2), 0.87 (6H, t, J 7.2 Hz, CH2CH3). 
13C-NMR (62.8 MHz, D2O): δ 135.6 (CH), 123.5 (CH), 122.2 
(CH), 49.6 (CH2), 48.7 (CH2), 31.1 (CH2), 18.7 (CH2) and 12.5 
(CH3); 
m/z (ESI): 275.2230 (M-HCl2˥
+), 138.1145 (M-Cl2˥
2+), 
C16H27N4 requires 275.2230, found 275.2228. IR (powder) ν:
 
3377, 3066, 2959, 2873, 2112, 1642, 1560, 1461, 1367, 1336, 
1162, 1112, 1023, 946, 857, 753, 637 cm-1. 
4.19. 1,3-Bis(1-butylimidazolium-3-yl)propane dichloride 
1H-NMR (400 MHz, D2O): δ 8.75 (2H, s, C(2)-H), 7.41 (4H, bs, 
C(4/5)-H), 4.22 (4H, t, J 7.2 Hz, NCH2), 4.09 (4H, t, J 7.2 Hz, 
NCH2), 2.42 (4H, quin, J 7.2 Hz, CH2CH2CH2), 1.74 (4H, quin, J 
7.5 Hz, CH2CH2), 1.22 (4H, quin, J 7.5 Hz, CH2CH3), 0.81 (6H, 
t, J 7.2 Hz, CH2CH3). 
13C-NMR (62.8 MHz, D2O): δ 135.4 (CH), 
122.8 (CH), 122.3 (CH), 49.6 (CH2), 46.5 (CH2), 31.2 (CH2), 
29.7 (CH2), 18.8 (CH2) and 12.7 (CH3); 
m/z (ESI): 289.2385 (M-
HCl2˥
+), 145.1225 (M-Cl2˥
2+), C17H29N4 requires 289.2387, found 
289.2385. IR (powder) ν: 3381, 3133, 1057, 2959, 2872, 2112, 
1704, 1641, 1562, 1459, 1370, 1335, 1160, 1114, 1021, 949, 872, 
753, 635 cm-1. 
4.20. 1,4-Bis(1-butylimidazolium-3-yl)butane dichloride 
1H-NMR (400 MHz, D2O): δ 8.77 (2H, s, C(2)-H), 7.46 (4H, bs, 
C(4/5)-H), 4.20 (4H, t, J 6.4 Hz, NCH2), 4.15 (4H, t, J 7.2 Hz, 
NCH2), 1.84 (4H, quin J 6.4 Hz, CH2), 1.76 (4H, t, J 7.5 Hz, 
CH2CH2), 1.25 (4H, quin, J 7.5 Hz, CH2CH3), 0.85 (6H, t, J 7.2 
Hz, CH2CH3). 
13C-NMR (62.8 MHz, D2O): δ 135.2 (CH), 122.6 
(CH), 122.1 (CH), 49.5 (CH2), 48.7 (CH2), 31.2 (CH2), 26.3 
(CH2), 18.8 (CH2) and 12.7 (CH3); 
m/z (ESI): 303.2542 (M-
HCl2˥
+), 152.1305 (M-Cl2˥
2+), C18H31N4 requires 303.2543, found 
303.2542. IR (powder) ν: 3383, 3133, 3064, 2959, 2872, 2106, 
1632, 1562, 1462, 1373, 1334, 1160, 1114, 1024, 949, 871, 754, 
634 cm-1. 
4.21. 1,5-Bis(1-butylimidazolium-3-yl)pentane dichloride 
1H-NMR (400 MHz, D2O): δ 8.70 (2H, s, C(2)-H), 7.39 (4H, bs, 
C(4/5)-H), 4.13-4.06 (8H, m, J 6.8, 7.2 Hz, NCH2), 1.85-1.69 
(8H, m, J 6.8, 7.2 Hz, CH2), 1.18 (6H, m, J 6.8, 7.6 Hz, CH2CH3 
and NCH2CH2CH2CH2), 0.80 (6H, t, J 7.6 Hz, CH3). 
13C-NMR 
(62.8 MHz, D2O): δ 135.1 (CH), 122.4 (CH), 122.2 (CH), 49.3 
(CH2), 31.2 (CH2), 28.6 (CH2), 24.96 (CH2) 22.12 (CH2) 18.7 
(CH2) and 12.6 (CH3); 
m/z (ESI): 317.2700 (M-HCl2˥
+), 159.1383 
(M-Cl2˥
2+), C19H33N4 requires 317.2700, found 317.2700. IR 
(powder) ν: 3375, 3133, 3069, 2958, 2930, 2871, 2112, 1765, 
1715, 1637, 1562, 1461, 1376, 1330, 1160, 1114, 1058, 1035, 
990, 869, 753, 638 cm-1. 
4.22. Bis(1-methyl-2-phenylimidazolium-3-yl)methane dichloride 
1H-NMR (400 MHz, D2O): δ 7.69 (4H, m, CH), 7.53 (4H, m, 
NCH), 7.37 (2H, m, CH), 7.25 (4H, d, J 7.6 Hz, CH), 6.41 (2H, s, 
 7 
NCH2N), 3.58 (6H, s, NCH3). 
13C-NMR (62.8 MHz, D2O): δ 
133.6 (CH), 130.1 (CH), 129.7 (CH), 124.2 (CH), 121.7 (CH), 
118.8 (CH), 58.1 (CH2) and 35.8 (CH2); 
m/z (ESI): 165.0914 (M-
Cl2˥
2+), C21H22N4 requires 165.0917, found 165.0914. IR 
(powder) ν: 3445, 3396, 3044, 1583, 1501, 1435, 1238, 1169, 
1095, 1032, 937, 782, 713, 692 cm-1. Anal. Calcd (%) for 
C21H22N4Cl2.2H2O: (MW 437.37): C, 57.67; H, 5.99; N, 12.81; 
Found (%): C, 57.04; H, 5.88; N, 12.56. 
4.23. 1,2-Bis(1-methyl-2-phenylimidazolium-3-yl)ethane 
dichloride 
1H-NMR (400 MHz, D2O): δ 7.92 (4H, m, CH), 7.82 (4H, s, 
NCH), 7.69 (2H, m, CH), 7.30 (4H, d, J 4 Hz, CH), 4.38 (4H, s, 
NCH2), 3.56 (6H, s, NCH3). 
13C-NMR (62.8 MHz, D2O): δ 145.0 
(CH), 133.2 (CH), 130.1 (CH), 129.6 (CH), 124.3 (CH), 121.4 
(CH), 119.4 (CH), 47.75 (CH2) and 35.6 (CH3); 
m/z (ESI): 
172.0994 (M-Cl2˥
2+), C22H24N4 requires 172.0995, found 
172.0994. IR (powder) ν: 3393, 3055, 2103, 1633, 1605, 1582, 
1507, 1474, 1439, 1327, 1251, 1218, 1171, 1097, 1026, 938, 776, 
708, 602 cm-1. Anal. Calcd (%) for C22H24N4Cl2.4H2O: (MW 
487.43): C, 54.21; H, 6.62; N, 11.49; Found (%): C, 54.28; H, 
6.43; N, 11.36. 
4.24. 1,3-Bis(1-methyl-2-phenylimidazolium-3-yl)propane 
dichloride 
1H-NMR (400 MHz, D2O): δ 7.71 (4H, m, CH), 7.60 (4H, m, 
NCH), 7.43 (2H, s, CH), 7.36 (4H, m, CH), 3.86 (4H, t, J 7.2 Hz, 
NCH2), 3.56 (6H, s, NCH3) and 2.03 (2H, quin, J 7.2 Hz, CH2). 
13C-NMR (62.8 MHz, D2O): δ 132.8 (CH), 129.9 (CH), 129.8 
(CH), 123.5 (CH), 121.2 (CH), 120.5 (CH), 45.0 (CH), 35.2 
(CH2) and 29.8 (CH3); 
m/z (ESI): 179.1075 (M-Cl2˥
2+), C23H26N4 
requires 179.1145, found 179.1075. IR (powder) ν: 3481, 3402, 
3344, 3234, 3071, 1633, 1580, 1510, 1451, 1330, 1247, 1156, 
1085, 945, 786, 787, 715 cm-1. Anal. Calcd (%) for 
C23H26N4Cl2.2H2O: (MW 465.42): C, 59.36; H, 6.50; N, 12.04; 
Found (%): C, 59.18; H, 6.40; N, 11.88. 
4.25. 1,4-Bis(1-methyl-2-phenylimidazolium-3-yl)butane 
dichloride 
1H-NMR (400 MHz, D2O): δ 7.68 (4H, m, CH), 7.56 (4H, m, 
NCH), 7.43 (2H, d, J 2.0 Hz, CH), 7.38 (4H, d, J 6.8 Hz, CH), 
3.80 (4H, t, J 6.8 Hz, NCH2), 3.56 (6H, s, NCH3) and 1.40 (4H, 
quin, J 6.8 Hz, CH2). 
13C-NMR (62.8 MHz, D2O): δ 144.6 (CH), 
132.7 (CH), 129.9 (CH), 129.7 (CH), 123.2 (CH), 121.4 (CH), 
120.8 (CH), 47.4 (CH2), 35.2 (CH2) and 25.4 (CH3); 
m/z (ESI): 
186.11150 (M-Cl2˥
2+), C24H28N4 requires 186.1152, found 
186.1150. IR (powder) ν: 3467, 3403, 3047, 3020, 1704, 1619, 
1580, 1516, 1480, 1468, 1449, 1392, 1319, 1258, 1241, 1159, 
1113, 1094, 1050, 1004, 953, 813, 784, 719, 707, 618, 555 cm-1. 
Anal. Calcd (%) for C24H28N4Cl2.2H2O: (MW 479.45): C, 60.12; 
H, 6.73; N, 11.68; Found (%): C, 59.76; H, 6.70; N, 11.40. 
4.26. 1,5-Bis(1-methyl-2-phenylimidazolium-3-yl)pentane 
dichloride 
1H-NMR (400 MHz, D2O): δ 7.66 (4H, m, CH), 7.60 (4H, m, 
NCH), 7.44 (2H, m, CH), 7.39 (4H, m, CH), 3.82 (4H, t, J 7.2 
Hz, NCH2), 3.57 (6H, s, NCH3) 1.43 (4H, quin, J 7.2 Hz, CH2) 
0.90 (2H, quin, J 7.2 Hz, CH2). 
13C-NMR (62.8 MHz, D2O): δ 
144.6 (C), 132.6 (CH), 130.1 (CH), 129.6 (CH), 123.1 (CH), 
121.4 (CH), 121.0 (C), 47.9 (CH2), 35.2 (CH3), 28.2 (CH2) and 
21.7 (CH2); 
m/z (ESI): 193.1230 (M-Cl2˥
2+), C25H30N4Cl2.4H2O 
requires 193.1230, found 193.1230. IR (powder) ν: 3503, 3405, 
3366, 3118, 3068, 1603, 1580, 1511, 1470, 1444, 1411, 1363, 
1328, 1245, 942, 785, 777, 705, 699, 619, 603 cm-1. Anal. Calcd 
(%) for C25H31N4Cl2.4H2O: (MW 529.50): C, 56.71; H, 7.23; N, 
10.58; Found (%): C, 57.02; H, 6.92; N, 10.48. 
4.27. Bis(1,2,4,5-tetramethylimidazolium-3-yl)methane 
dichloride 
1H-NMR (400 MHz, D2O): δ 6.36 (2H, s, NCH2), 3.60 (6H, s, 
NCH3), 2.57 (6H, s, CCH3), 2.14 (6H, s, CCH3) and 1.98 (6H, s, 
CCH3). 
13C-NMR (62.8 MHz, D2O): δ 144.0 (CH2), 128.2 (CH2), 
125.3 (CH2), 54.7 (CH2), 32.0 (CH3), 10.0 (CH3), 7.9 (CH3) and 
7.6 (CH3); 
m/z (ESI): 261.2075 (M-HCl2˥
+), 131.1071 (M-Cl2˥
2+), 
C15H25N4 requires 261.2074, found 261.2075. IR (powder) ν:
 
3446, 3370, 2985, 2121, 1652, 1623, 1542, 1507, 1443, 1396, 
1364, 1329, 1239, 1205, 1140, 1077, 1037, 865, 846, 822, 711, 
590, 567 cm-1. Anal. Calcd (%) for C15H26N4Cl2.3H2O: (MW 
387.35): C, 46.51; H, 8.33; N, 14.46; Found (%): C, 45.34; H, 
8.38; N, 14.02. 
4.28. 1,2-Bis(1,2,4,5-tetramethylimidazolium-3-yl)ethane 
dichloride 
1H-NMR (400 MHz, D2O): δ 4.40 (4H, s, NCH2), 3.55 (6H, s, 
NCH3), 2.31 (6H, s, CCH3), 2.13 (6H, s, CCH3), 1.99 (6H, s, 
CCH3). 
13C-NMR (62.8 MHz, D2O): δ 142.7 (C), 127.3 (C), 
125.2 (C), 43.8 (CH2), 31.7 (CH3), 9.0 (CH3), 7.6 (CH3) and 7.2 
(CH3); 
m/z (ESI): 275.2232 (M-HCl2˥
+), 138.1149 (M-Cl2˥
2+), 
C16H27N4 requires 275.2230, found 275.2232. IR (powder) ν:
 
3427, 3385, 2975, 2117, 1644, 1617, 1541, 1525, 1481, 1442, 
1379, 1357, 1339, 1272, 1230, 1182, 1135, 1077, 1047, 851, 835, 
768, 667, 613, 564 cm-1. Anal. Calcd (%) for 
C16H28N4Cl2.2.5H2O: (MW 392.37): C, 48.98; H, 8.47; N, 14.28; 
Found (%): C, 48.56; H, 8.44; N, 14.17. 
4.29. 1,3-Bis(1,2,4,5-tetramethylimidazolium-3-yl)propane 
dichloride 
1H-NMR (400 MHz, D2O): δ 4.09 (4H, t, J 7.1 Hz, NCH2), 3.53 
(6H, s, NCH3), 2.53 (6H, s, CCH3), 2.47 (6H, s, CCH3), 2.11 (6H, 
s, CCH3) and 1.08 (2H, quin, J 7.1 Hz CH2). 
13C-NMR (62.8 
MHz, D2O): δ 142.1 (C), 126.4 (C), 124.6 (C), 41.6 (CH3), 31.2 




2+), C17H29N4 requires 
289.2387, found 289.2388. IR (powder) ν: 3370, 3284, 2983, 
2923, 2110, 1643, 1528, 1430, 1376, 1351, 1227, 1206, 1177, 
1064, 1037, 853, 824, 767, 644, 577, 561 cm-1. Anal. Calcd (%) 
for C17H30N4Cl2.4H2O: (MW 433.42): C, 47.11; H, 8.84; N, 
12.93; Found (%): C, 46.74; H, 8.96; N, 12.68. 
4.30. 1,4-Bis(1,2,4,5-tetramethylimidazolium-3-yl)butane 
dichloride 
1H-NMR (400 MHz, D2O): δ 3.97 (4H, t, J 5.0, NCH2), 3.50 (6H, 
s, NCH3), 2.45 (6H, s, CCH3), 2.13 (6H, s, CCH3), 2.13 (6H, s, 
CCH3) and 1.66 (4H, quin, J 5.0 Hz, CH2). 
13C-NMR (62.8 MHz, 
D2O): δ 142.0 (C), 126.5 (C), 124.6 (C), 44.2 (CH2), 31.2 (CH3), 




2+), C18H31N4 requires 
303.2543, found 303.2546. IR (powder) ν: 3386, 3340, 2986, 
2875, 2100, 1649, 1609, 1533, 1448, 1416, 1373, 1224, 1167, 
1078, 1042, 838, 759, 692 cm-1. Anal. Calcd (%) for 
C18H32N4Cl2.4H2O: (MW 447.44): C, 48.32; H, 9.01; N, 12.52; 
Found (%): C, 47.40; H, 8.48; N, 12.58. 
4.31. 1,5-Bis(1,2,4,5-tetramethylimidazolium-3-yl)pentane 
dichloride 
1H-NMR (400 MHz, D2O): δ 3.93 (4H, t, J 7.6 Hz, NCH2), 3.46 
(6H, s, NCH3), 2.48 (6H, s, CCH3), 2.48 (6H, s, CCH3), 2.10 (6H, 
s, CCH3), 1.73 (4H, quin, J 7.6 Hz, CH2) and 1.26 (2H, q, J 7.6 
Hz, CH2). 





124.7 (C), 45.1 (CH2), 31.1 (CH3), 28.5 (CH2), 22.9 (CH2), 9.2 
(CH3) and 7.54 (CH3), 6.7 (CH3); 
m/z (ESI): 159.1384 (M-Cl2˥
2+), 
C19H34N4 requires 159.1386, found 159.1384. IR (powder) ν: 
3368, 2927, 2865, 2116, 1703, 1645, 1531, 1433, 1373, 1227, 
1132, 1076, 1046, 863, 839, 739, 599 cm-1. 
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